Accordingly, systemic administration of Met-CCL5 or (44)AANA(47)-CCL5, a mutated CCL5 protein, led to a strong attenuation of experimental liver fibrosis in vivo[10], [29]. Here, CCL5 is linked to Hepatic fibrosis.